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Cutaneous tissue repair aims at restoring the barrier function of the skin. To achieve this, defects need to be
replaced by granulation tissue to form new connective tissue, and epithelial wound closure is required to
restore the physical barrier. Different wound-healing phases are recognized, starting with an inflammation-
dominated early phase giving way to granulation tissue build-up and scar remodeling after epithelial wound
closure has been achieved. In the granulation tissue, mesenchymal cells are maximally activated, cells
proliferate, and synthesize huge amounts of extracellular matrix. Epithelial cells also proliferate and migrate
over the provisional matrix of the underlying granulation tissue, eventually closing the defect. This review
focuses on the role of keratinocyte–fibroblast interactions in the wound-healing process. There is ample
evidence that keratinocytes stimulate fibroblasts to synthesize growth factors, which in turn will stimulate
keratinocyte proliferation in a double paracrine manner. Moreover, fibroblasts can acquire a myofibroblast
phenotype under the control of keratinocytes. This depends on a finely tuned balance between a
proinflammatory or a transforming growth factor (TGF)-b-dominated environment. As the phenotype of
fibroblasts from different tissues or body sites becomes better defined, we may understand their individual
contribution in wound healing in more detail and possibly explain different clinical outcomes.
Journal of Investigative Dermatology (2007) 127, 998–1008. doi:10.1038/sj.jid.5700786
Epithelial–mesenchymal interactions in
tissue repair
After cutaneous injury a cascade of
events is observed, which mediates
tissue repair and eventually the re-
establishment of the barrier function
of the skin. Tissue repair has been
divided into an inflammatory phase, a
granulation phase with synthesis of
new connective tissue and epithelial
wound closure, and finally a scar-
remodeling phase once the epidermal
barrier has been re-established.
Throughout the whole repair process
interaction between different cell types
provides coordination of the individual
events, allowing for a temporal and
spatial control. In the mid- and late
phase of wound healing, cellular inter-
actions become dominated by the inter-
play of keratinocytes with fibroblasts,
which gradually shift the microenviron-
ment away from an inflammatory to a
synthesis-driven granulation tissue.
Epithelial–mesenchymal interactions
are also crucial for pre- and postnatal
skin development, and they play an
important role in tumor biology. During
development, tightly controlled mutual
interactions between the epidermis and
the mesenchyme control the formation
of limbs, skin architecture, and appen-
dages through gradients of morphogens
and differential sensitivity of target cells
for these diffusible mediators. Thus,
highly complex, cell-type-specific re-
sponses can be achieved. After a series
of these interactions, limb or skin
appendages eventually form (reviewed
by Schmidt-Ullrich and Paus, 2005;
Tickle, 2006). There is strong evidence
that these patterns of epithelial–me-
senchymal interactions persist in adult
life and regulate skin homeostasis, part
of the wound-healing response (Martin
and Parkhurst, 2004), or become criti-
cally involved in tumor cell invasion
and tumor progression (Bhowmick
et al., 2004; Mueller and Fusenig,
2004).
The epidermal phenotype
Keratinocytes in skin represent a con-
stantly renewing cellular compartment,
and stem cells have raised continuous
interest from a scientific as well as
therapeutic aspect. Epidermal stem
cells have been characterized largely
on their functional properties and
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The following 3 articles by Werner
et al., Stramer et al., and Clark
et al. continue the Wound Healing
Perspectives Series which began in
the March 2007 issue of the journal.
Received 25 October 2006; revised 8 December 2006; accepted 14 December 2006
1Institute of Cell Biology, Eidgeno¨ssische Technische Hochschule Zu¨rich, Ho¨nggerberg, Zu¨rich, Switzerland and 2Department of Dermatology, University of
Cologne, Cologne, Germany
Correspondence: Dr Hans Smola, Paul Hartmann AG, PO Box 1420, Heidenheim D-89504, Germany. Email: hans.smola@hartmann.info
3Current address: Paul Hartmann AG, PO Box 1420, Heidenheim 89504, Germany.
Abbreviations: a-SMA, a-smooth muscle action; EGF, epidermal growth factor; KGF/FGF7, keratinocyte growth factor/fibroblast growth factor 7; PDGF, platelet-
derived growth factor; TGF, transforming growth factor; TNF, tumor necrosis factor
marker expression (Barrandon and
Green, 1987; Cotsarelis et al., 1990;
Oshima et al., 2001; Tumbar et al.,
2004; Jensen and Watt, 2006), never-
theless their exact nature still remains
somewhat elusive. The role of epithe-
lial–mesenchymal interactions for the
keratinocyte stem cell phenotype was
demonstrated early (Rheinwald and
Green, 1975). The feeder cell-culture
system demonstrated clearly that the
epidermal stem cell phenotype de-
pends on the interaction with mesench-
ymal cells. Primary keratinocytes are
seeded at clonal density onto growth-
inhibited fibroblasts, which serve as
feeder cells. Within 7–10 days, the
cultures become confluent and kerati-
nocytes can be passaged with high
efficiency. There appears to be flex-
ibility concerning the source of the
fibroblasts, as murine fibroblasts can be
substituted by human skin fibroblasts
(Limat et al., 1990). Apparently, the
mesenchymal feeder cells provide a
microenvironment, which supports the
stem cell phenotype and augments
epidermal proliferation. Growth factors
play a critical role and are added to the
culture medium to support epidermal
proliferation. However, even complex
growth factor mixtures can hardly re-
place the net effect of mesenchymal
feeder cells when keratinocytes are
seeded at clonal densities. It became
apparent that keratinocytes in these
cultures instruct fibroblasts to synthe-
size and secrete growth factors and
cytokines, such as keratinocyte growth
factor (KGF)/fibroblast growth factor-7
(FGF7), IL-6, and GM-CSF (Waelti
et al., 1992; Smola et al., 1993; Box-
man et al., 1996). Expression of these
factors can be induced by IL-1, and
indeed, keratinocyte-derived IL-1 was
identified as primary inductor (Waelti
et al., 1992; Maas-Szabowski and
Fusenig, 1996; Maas-Szabowski et al.,
1999). Szabowski et al. (2000) had
elegantly shown that in fibroblasts, the
transcription factor activator protein-1
plays a central role in this paracrine
growth factor loop. Activator protein-1-
dependent KGF/FGF7, GM-CSF, pleio-
trophin, and stromal cell-derived factor
1 expression regulate keratinocyte pro-
liferation and differentiation in kerati-
nocyte–fibroblast cocultures (Florin
et al., 2005). The concept of double
paracrine signaling was proposed
where keratinocytes initiate growth
factors in fibroblasts, which themselves
stimulate keratinocyte proliferation.
Apart from paracrine growth factor
regulation, the formation of a new
basement membrane zone is another
example where interaction between
keratinocytes and fibroblasts are cru-
cially involved. Basement membrane
constituents and a fully organized
basement membrane can influence
the keratinocyte phenotype (El Ghalb-
zouri et al., 2004). Recombination
experiments have detailed the expres-
sion pattern and cellular origin of
basement membrane and extracellular
matrix constituents in epidermal–der-
mal cultures (Regauer et al., 1990;
Fleischmajer et al., 1997; Smola et al.,
1998). Laminin-5 is of epithelial origin,
collagen VII primarily produced by
keratinocytes and to a lesser extent by
fibroblasts (Marinkovich et al., 1993),
whereas nidogen is exclusively derived
from fibroblasts. The other basement
membrane components are produced
in both cell types with mutual induc-
tion patterns. Apart from matrix-de-
rived signals, which help to maintain
the epidermal stem cell phenotype,
proteolytic processing can generate
laminin-5 fragments, which can stimu-
late epidermal growth factor (EGF)
receptor signaling and proliferation
(Schenk et al., 2003). Extracellular
matrix also modulates cellular func-
tions directly and this has been exten-
sively studied in fibroblasts (Eckes
et al., 2006). This involves binding of
matrix molecules to adhesion recep-
tors, and mechanical tension plays a
critical role in regulating the de novo
synthesis of collagens. Interestingly,
fibroblasts in collagen gels and also in
the granulation tissue form gap junc-
tions, which are also involved in the
regulation of extracellular matrix pro-
duction (Ehrlich and Diez, 2003; Ehr-
lich et al., 2006). In a polyvinyl alcohol
sponge implant model, a gap junction
uncoupler reduced the number of cells
migrating into the sponges, the myofi-
broblast density and collagen deposi-
tion and organization (Ehrlich and
Diez, 2003). Thus, epithelial–mesench-
ymal cocultures provide an environ-
ment where the epidermal stem cell
phenotype and keratinocyte prolifera-
tion are supported by a synergistic
mix of growth factors, extracellular
matrix components, and direct cell–cell
contacts. This concept has been excel-
lently reviewed by Nelson and Bissell
(2006).
Growth factor-mediated cross talk be-
tween keratinocytes and fibroblasts
Growth factor networks have been
identified in the above-described tissue
culture systems. In the meantime, the
existence of at least some of these
networks has been verified in vivo in
normal and wounded skin. In particu-
lar, studies with genetically modified
animals have advanced our under-
standing in this field, and the wound-
healing phenotypes of different trans-
genic and knockout mice has been
reviewed previously (Grose and Wer-
ner, 2004). Furthermore, a website has
been set up, which summarizes these
phenotypes (http://icbxw.ethz.ch/
woundtransgenic/home.html).
One of the first growth factors,
which was shown to be involved in
mesenchymal–epithelial interactions, is
KGF/FGF7, which is rapidly induced in
fibroblasts after wounding and which
exerts its effects through binding to its
receptor FGFR2IIIb on keratinocytes.
Some growth factors are predominantly
expressed in epidermal cells and exert
their actions on mesenchymal cells,
such as platelet-derived growth factor
(PDGF). For other growth factors, ex-
pression was detected in both kerati-
nocytes and the mesenchymal cell
compartment and the effects were
observed in both cell compartments in
an autocrine and paracrine fashion.
Activins are typical examples (for re-
view, see Werner and Grose, 2003).
Paracrine acting mesenchymally derived
growth factors
As mentioned above, KGF/FGF7 is the
prototype of a mesenchymally derived
growth factor, which stimulates epider-
mal proliferation (Finch et al., 1989;
Rubin et al., 1989). On injury, KGF/
FGF7 expression is strongly upregu-
lated in mesencymal cells (Werner
et al., 1992; Marchese et al., 1995).
IL-1, tumor necrosis factor-a (TNF-a),
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PDGF, and serum were shown to
stimulate KGF expression, and all these
inducers are present at the early stages
of wound healing (Brauchle et al.,
1994; Chedid et al., 1994). Expression
of a dominant-negative FGFR2IIIb mu-
tant in basal keratinocytes of transgenic
mice caused epidermal thinning, hair
follicle abnormalities, dermal fibrosis,
and a severe delay in wound re-
epithelialization (Werner et al., 1994).
However, the dominant-negative mu-
tant blocks signaling by all FGF recep-
tors in response to common ligands,
and the type of FGF and FGFR, which is
involved in wound healing, remained
therefore unclear. Subsequent analysis
of mice deficient for FGF7/KGF showed
that healing of incisional wounds is not
impaired (Guo et al., 1996), suggesting
that other factors like fibroblast-derived
FGF10, which also signals through the
FGFR2IIIb receptor, may compensate
in this experimental model, which
requires little epidermal healing.
FGF10 is also expressed in fibroblasts,
but unlike FGF7/KGF, FGF10 expres-
sion is not induced during wound
healing. Transforming growth factor-b
(TGF-b) and TNF-a repress FGF10
expression, suggesting a differential
regulation of FGF10 and FGF7 (Beer
et al., 1997a). Recently, another FGF
family member, FGF22, has been
identified, which also can activate
FGFR2IIIb (Zhang et al., 2006). Inter-
estingly, the predominant cell type
expressing FGF22 are keratinocytes
(Nakatake et al., 2001; Beyer et al.,
2003). Therefore, FGF22 is considered
to act in an autocrine fashion, and high
expression of this FGF was seen in the
late stages of the wound-healing re-
sponse. The activity of these FGFRIIIb
ligands may be enhanced by the FGF-
binding protein. FGF-binding protein is
synthesized in the epidermis, and it is
upregulated during wound healing. It
binds FGF7, -10, -22 and enhances
activity of ligands at low concentra-
tions (Beer et al., 2005).
IL-6 has been shown to stimulate
epidermal cell proliferation (Grossman
et al., 1989), and its expression is
strongly upregulated in keratinocyte–fi-
broblast cocultures in comparison to
monocultures. In mice deficient for IL-
6, excisional wound healing was se-
verely retarded. This is very well in line
with its presumed role in mesenchy-
mal–epidermal cell–cell communica-
tion (Gallucci et al., 2000; Lin et al.,
2003). In addition, fewer leukocytes
were observed in the wounds of IL-6-
deficient mice as well as decreased
angiogenesis and collagen accumula-
tion. The phenotype could be mi-
micked by injecting a neutralizing
mAb into wild-type mice (Lin et al.,
2003) and rescued by injection of a
single dose of IL-6 into IL-6-deficient
mice (Gallucci et al., 2000).
In addition to KGF/FGF7 and IL-6,
other factors, such as hepatocyte
growth factor and GM-CSF are primar-
ily produced by mesenchymal cells and
act on keratinocytes following the same
paracrine pattern (Smola et al., 1993;
Maas-Szabowski and Fusenig, 1996;
Szabowski et al., 2000; Gron et al.,
2002).
Keratinocyte-derived growth factors
KGF/FGF7 and IL-6 are predominantly
expressed in the mesenchyme and
target keratinocytes. There are also
examples where keratinocytes are the
primary source of growth factors,
which may stimulate not only kerati-
nocytes themselves but also fibroblasts
or other mesenchymal cell types.
TGF-a is predominantly expressed in
keratinocytes and has a profound auto-
crine effect on keratinocytes in wound
healing. Expression of this growth
factor is upregulated in keratinocytes
after skin injury (Antoniades et al.,
1993). EGF as well as TGF-a activity
were detected in wound fluid from rats
(Grotendorst et al., 1989) and humans
(Ono et al., 1995). Furthermore, kera-
tinocytes bordering the epithelial de-
fect as well as epithelial cells in hair
follicles were found to express high
levels of TGF-a, particularly in the
strongly proliferating cells. High TGF-
a expression is also a hallmark of
psoriatic epidermis and appears to be
associated with keratinocyte hyperpro-
liferation (Gottlieb et al., 1988; Elder
et al., 1989). Surprisingly, wound-
healing experiments in TGF-a-deficient
mice showed no abnormal wound-
healing phenotype (Luetteke et al.,
1993; Mann et al., 1993) and only on
closer examination and in wound-
healing models where epithelial migra-
tion is critical for healing small differ-
ences were observed (Kim et al., 2001).
Less clear is the role of TGF-a on
mesenchymal cells in wound healing.
It is a strong mitogen for fibroblasts
(Rosenthal et al., 1986) and augments
angiogenesis (Schreiber et al., 1986).
However, the lack of an obvious
mesenchymal phenotype in TGF-a-de-
ficient mice suggests that this growth
factor is dispensable for fibroblast pro-
liferation and/or angiogenesis and that
its loss can be compensated by other
EGFR ligands. Heparin-binding EGF
might be a possible candidate, since it
was also detected in wound fluid of
partial thickness wounds and of pedia-
tric burn patients (Marikovsky et al.,
1993) as well as in migrating keratino-
cytes in a mouse burn wound model
(Cribbs et al., 2002). Heparin-binding
EGF is mitogenic for both keratinocytes
(Cribbs et al., 2002) and fibroblasts and
can synergize with IGF I (Marikovsky
et al., 1993). Furthermore, keratino-
cyte-specific inactivation of the hb-egf
gene resulted in delayed epithelial
wound closure in mice, suggesting that
heparin-binding EGF is involved in
epithelialization by accelerating kerati-
nocyte migration, rather than prolifera-
tion (Shirakata et al., 2005).
PDGF is another predominantly
keratinocyte-derived growth factor act-
ing in a paracrine manner. This growth
factor is immediately released after
wounding by degranulating platelets.
Without the time-consuming de novo
synthesis at the wound site, PDGF
activity is readily available within
minutes after injury. Later during tissue
repair, PDGF is synthesized in the
wound tissue. PDGF transcripts and
protein were detected in the epithelium
(Antoniades et al., 1991; Ansel et al.,
1993; Beer et al., 1997a, b), whereas
transcripts in mesenchymal cells were
described by Antoniades et al. (1991)
also. The corresponding receptors were
detected in mesenchymal cells (Ansel
et al., 1993) and in one report on
keratinocytes as well (Antoniades et al.,
1991). Fibroblast- and keratinocyte-
derived PDGF-AA has little effect on
these cells, as the predominant PDGF
receptor-b is little responsive to the
PDGF-AA isoform (Bonner et al., 1991)
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also. On the other hand, different cell
types in healing skin wounds express
the PDGF-BB isoform for which the
fibroblasts are responsive and which is
able to induce KGF in mesenchymal
cells (Brauchle et al., 1994; Beer et al.,
1997a, 1997b). The expression pattern
suggests a paracrine signaling from the
epidermis to mesenchymal cells as well
as autocrine signaling in the granula-
tion tissue. Moreover, neutralizing
PDGF antibodies reduced the mito-
genic activity of acute wound fluid by
45% when tested on fibroblasts (Katz
et al., 1991), indirectly supporting this
assumption.
Growth factors expressed in keratino-
cytes and mesencymal cells
Activins are members of the TGF-b
family of growth and differentiation
factors. They are homo- or heterodi-
meric polypeptides consisting of bA, bB,
bC, bD, and bE chains. The bA and bB
chains are expressed in keratinocytes as
well as in the mesenchyme on wound-
ing (Hubner et al., 1996b). The bC and
bE chains are predominantly found in
other tissues (Vejda et al., 2002) and
the bD subunit is present only in
Xenopus laevis but not in mammals.
Epidermal overexpression of the activin
bA under the control of a keratin 14
promoter caused a dermal phenotype
mostly characterized by a loss of
adipose tissue, which was replaced by
a fibrosing dermis, and a hyperprolifer-
ating epidermis (Munz et al., 1999).
The epidermal phenotype was unex-
pected, as activin was shown to be
growth inhibitory for keratinocytes in
vitro (Seishima et al., 1999). Therefore,
it seems likely that the phenotype is at
least in part mediated via mesenchymal
cells. Of particular interest was the
enhanced wound healing in activin-
overexpressing mice. Granulation tis-
sue formation was particularly affected,
but faster re-epithelialization was also
Table 1. Differential mRNA expression pattern of fibroblasts cocultured with HaCaT keratinocytes for 4 days
Genes induced in cocultured fibroblasts
Proteases and inhibitors Extracellular matrix components Cell – Cell signaling associated Cytoskeleton associated
PAI-1 Collagen V alpha 3 ENA 78 SM22 alpha
Collagen IV alpha 1 MCP1 Integrin alpha 1
Hyaluronan synthetase 2 Activin A Tropomyosin 2 beta
Lysine hydroxylase 2 LTBP 1 Tropomyosin 1 alpha
Transglutaminase 2 Interleukin 6 VASP
Collagen V alpha 1 CTGF Calponin 1 (basic)
Collagen I alpha 1 HB-EGF Smooth muscle actin alpha2
Tenascin C (GP) Endothelin 1 n-chimaerin
Decorin (PG) Angiopoetin 1 MLCK
Collagen VI alpha 3 WNT 5A Integrin alpha 5
Syndecan 2 (PG) LIF
COX 2
G-CSF
WNT 2
Dickkopf 3
Genes downregulated in cocultured fibroblasts
Proteases and inhibitors Extracellular matrix components Cell – Cell signaling associated Cytoskeleton associated
Cathepsin K Fibulin 4 TGF beta receptor III Integrin alpha 4
Cathepsin L Testican Prostaglandin F Receptor
Cathepsin L2 Tenascin XA Follistatin
Fibulin 1 gp130 Receptor
Glypican 1 Osteoprotegerin Receptor
Thrombospondin 2 Toll Like Receptor 4
EGF Receptor
HGF Receptor
MCSF
Stromal cell-derived factor
The expression pattern has been clustered according to their potential function (Figure 1). Adapted from Shephard et al. (2004b).
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observed. As a consequence, however,
the mice also showed an extended scar
area (Munz et al., 1999; S.W. unpub-
lished data). To study the role of
endogenous activin in wound repair,
mice overexpressing the soluble activin
antagonist follistatin in the epidermis
were generated (Wankell et al., 2001).
These mice showed a severe delay in
wound healing, and granulation tissue
formation was particularly affected.
However, the wounds finally healed,
and the resulting scar was smaller than
in control animals. These findings
demonstrated that the levels of bioac-
tive activin in a wound determine the
speed of wound repair but also the
scarring response. To determine if
activin affects wound healing via ker-
atinocytes or mesenchymal cells or
both, transgenic mice expressing a
dominant-negative activin receptor
mutant in keratinocytes were gener-
ated. Their skin architecture was almost
unchanged compared with control
mice. Wound re-epithelialization was
slightly delayed owing to reduced
keratinocyte migration. However, the
strong inhibition of granulation tissue
formation seen in the follistatin-over-
expressing mice was not observed in
the transgenic mice expressing the
dominant-negative activin receptor
mutant in keratinocytes, demonstrating
that activin exerts its effect on wound
healing predominantly via stromal cells
(Bamberger et al., 2005).
The fibroblast phenotype in epidermal–-
mesenchymal interactions
Most of the studies described above
analyzed the phenotype of the epider-
mis, as delayed wound closure is often
due to reduced keratinocyte migration
or proliferation. By contrast, much less
is known about the changes that
mesenchymal cells undergo in healing
skin wounds. From wound-healing
studies, it has long been known that
myofibroblasts start to appear in the
granulation tissue around the mid-
phase of wound healing. This coincides
with a strong induction of contractile
properties so that cells align parallel to
mechanical tension that is building up
in the granulation tissue. Myofibro-
blasts appear to differentiate from
fibroblasts by acquiring the smooth
muscle cell actin isoform a-smooth
muscle action (a-SMA). Several studies
investigated the mechanisms on how
fibroblasts become myofibroblasts, and
it seems that the two most important
stimuli are mechanical tension (Hinz
et al., 2001) and TGF-b activity (Des-
mouliere et al., 1993).
To analyze how fibroblasts respond
to keratinocyte-derived stimuli, the
messenger RNA (mRNA) expression
pattern of fibroblasts in monoculture
was compared with the fibroblasts
cocultured with keratinocytes (Shep-
hard et al., 2004b). To reduce the
complexity of the experimental system
HaCaT keratinocytes were cultured on
a feeder layer of fibroblasts. HaCaT
cells in these experiments had the
advantage that the epidermal pheno-
type was relatively stable although
normal epidermal architecture is ob-
served only after transplantation onto
nude mice (Boukamp et al., 1997) or
after addition of TGF-a in organotypic
cultures (Maas-Szabowski et al., 2003).
When HaCaT keratinocytes reached
50% confluence, cocultured fibroblasts
were isolated by differential EDTA
treatment. Comparing the RNA expres-
sion pattern of cocultured and control
fibroblasts revealed differential expres-
sion of growth factor, extracellular
matrix, protease, and intracellular
structural protein transcripts (Table 1).
The intracellular structural proteins
suggested that fibroblasts differentiated
into myofibroblasts as shown by a time-
dependent increase of a-SMA-positive
mesenchymal cells. The expression
Keratinocytes
ECM
KGF, IL-6, GM-CSF
HGF, actin, TGF-
HB-EGF
IL-1, activin,
TGF-
Fibroblast Proto-myofibroblast
(tension +)
Myofibroblast
(tension + + +)
TGF-, ET-1 TGF-
Figure 1. Proposed model for the modulation of fibroblast differentiation in keratinocyte-fibroblast co-
cultures. At early stages after injury proinflammatory mediators, such as keratinocyte-derived IL-1,
dominate keratinocyte–fibroblast interactions. At this time, TGF-b activity is strongly upregulated in
keratinocyte–fibroblast cocultures but NFkB activation in fibroblasts blocks TGF-b signaling. IL-1-
responsive genes, such as the genes for KGF, IL-6, endothelin-1 (ET-1), heparin-binding EGF and GM-
CSF, are upregulated in fibroblasts. These factors can then stimulate keratinocyte proliferation and
differentiation. Basement membrane constituents are expressed by both keratinocytes, and to a lesser
extent, by fibroblasts. ET-1, besides, TGF-b initiates early contractile activity and mechanical tension
starts to build up. Fibroblasts are negative for a-SMA expression at this stage. In the mid-phase of
keratinocyte–fibroblast interactions, the balance of keratinocyte-derived IL-1 and TGF-b effects starts to
shift. NFkB activation in fibroblasts is decreasing and TGF-b-dependent gene expression is becoming
upregulated. Fibroblasts start to increase their synthesis of basement membrane constituents. At this
stage, fibroblasts are still largely negative for a-SMA expression, but mechanical tension is building up in
a second peak. They may be best described as proto-myofibroblasts. In mature keratinocyte–fibroblast
interactions, TGF-b effects fully govern the fibroblast phenotype. ET-1 and TGF-b synergize in the
induction of a-SMA, and the majority of fibroblasts has acquired a-SMA expression and differentiated into
myofibroblasts. Mechanical tension is highly developed in fibroblasts in close vicinity to keratinocytes.
Keratinocyte-derived IL-1 is still present, but the remaining NFkB activation in fibroblasts appears to
block TGF-b signaling only mildly. Basement membrane constituents are strongly expressed in fibroblasts
and contribute to the formation of an organized basement membrane zone.
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data showed that several genes char-
acteristic of TGF-b signaling were
upregulated. They encode, among
others, plasminogen-activator inhibi-
tor-1, a-SMA and collagen type 1.
HaCaT keratinocytes as well as fibro-
blast monocultures produced low
amounts of TGF-b, which was mostly
in the latent form. In cocultures, how-
ever, there was a strong increase in
latent and active TGF-b. Surprisingly,
high levels of active TGF-b protein
were already detected in cocultures
after 24 and 48 hours, whereas the
differentiation into myofibroblasts
started to be seen only after 4 days
and later. This raised the question
whether there were inhibitors in the
keratinocyte–fibroblast cocultures,
which may delay the TGF-b effects.
And indeed, NFkB was strongly in-
duced in cocultured fibroblasts within
the first 2 hours, persisting for the first 2
days, and slowly waning off until day 7.
NFkB activation was shown to interfere
with TGF-b signaling (Bitzer et al.,
2000; Nagarajan et al., 2000; Verrec-
chia et al., 2000). Further experiments
supported the assumption of a role of
NFkB as an inhibitor of TGF-b-
mediated effects in fibroblasts, as exo-
genously added IL-1 was able to
completely suppress a-SMA induction
in cocultures. Further, inhibition of
keratinocyte-derived IL-1 increased a-
SMA expression (Shephard et al.,
2004b). When keloid keratinocytes
and fibroblasts were used in cocultures,
increased expression of TGF-b was
observed, which is responsible for the
enhanced proliferation rate of the
mesenchymal cells (Xia et al., 2004).
In these cocultures keloid keratinocytes
expressed more TGF-b1 and -b3 than
normal keratinocytes. Keloid fibroblasts
had increased the levels for TGF-b1-
and b2 mRNA and produced more
collagen I, connective tissue growth
factor, and IGF-II/mannose-6-phos-
phate receptor. Interestingly, keloid
fibroblasts also showed a constitutive
increase in NFkB-binding activity with
and without TNF-a treatment when
compared with normal skin fibroblasts
(Messadi et al., 2004). Whether target-
ing of the NFkB pathway represents a
novel therapeutic intervention for the
treatment of keloid scarring remains to
be elucidated. At present, the in vitro
data suggest that keratinocytes and
fibroblasts in cocultures produce sig-
nificant amounts of active TGF-b, but
proinflammatory cytokines determine
the degree of cellular responsiveness in
fibroblasts.
Keratinocyte–fibroblast interactions in-
crease contractile activity in mesenchy-
mal cells
Apart from TGF-b signals, myofibro-
blast differentiation is also regulated by
mechanical tension (reviewed by To-
masek et al., 2002). In cocultures,
fibroblasts readily acquired contractile
properties already after 1 and 2 days
when compared with control cultures
(Shephard et al., 2004a). In these
experiments, the cells were cultured
on deformable silicone substrates.
When cells start to exert contractile
forces, the underlying substrate forms
wrinkles and this can be observed in
phase contrast microscopy. Contractile
activity persisted in cocultures for the
observational period of 7 days. Wrin-
kles were predominantly formed where
keratinocytes and fibroblasts were in
close proximity, reminiscent of a-SMA
induction, which also required close
proximity of both cell types. At early
time points, the underlying mechanism
was unclear, as fibroblasts had not yet
acquired a-SMA expression. The initial
complementary DNA array data sug-
gested that endothelin-1 might have
induced contraction of fibroblasts in
the cocultures. Endothelin-1 peptide
was upregulated in cocultures from
early time points on, and inhibition
with PD156252, a specific inhibitor at
the receptor level, was able to prevent
contraction in cocultured fibroblasts.
Interestingly, inhibition occurred only
at early time points. At later time points
when a-SMA was induced, contraction
was unaffected by endothelin inhibi-
tion. PD156252 inhibited induction of
a-SMA expression in cocultured fibro-
blasts to some extent though not
completely. Only the combination of
endothelin and TGF-b inhibition sup-
pressed a-SMA induction. Thus there
appears to be a cooperative effect
of mechanical tension and TGF-b
sensitivity in keratinocyte–fibroblast
cocultures.
Apart from whole cells, a number of
growth factors were shown to modulate
contractile activity of fibroblasts in
collagen gels. The PDGF-AA and -BB
isoforms and TGF-b1 led to efficient
collagen–gel contraction, although
TGF-b treatment resulted in a delayed
onset and a slower rate of contraction.
IL-1a on the other hand inhibited
collagen–gel contraction and caused
degradation of the collagen gels at later
time points, most likely due to en-
hanced matrix metalloproteinase activ-
ity (Tingstrom et al., 1992). Further-
more, mechanical tension was shown
to inhibit the normally observed apop-
tosis in collagen gel-embedded fibro-
blasts (Fluck et al., 1998; Grinnell
et al., 1999; Niland et al., 2001), and
the gene expression pattern was differ-
entially regulated by mechanical ten-
sion in normal fibroblasts (Kessler et al.,
2001).
IL-1, TNF-a, and TGF-b expression dur-
ing wound healing
The findings described above raise the
question how the key players for the
interaction between keratinocytes and
fibroblasts are regulated in wounded
skin. IL-1 and TNF-a expression were
analyzed in excisional wound-healing
experiments in mice. Within 8 hours
there was a strong induction of IL-1b
and slightly later TNF-a mRNA, which
persisted until the wounds were in the
mid-phase of healing (Hubner et al.,
1996a). Granulocytes are the first cells
to appear at the wound site and
produce high levels of these proinflam-
matory cytokines (Feiken et al., 1995).
Later, macrophages in the granulation
tissue and keratinocytes become the
predominant source (Hubner et al.,
1996a). Blocking TNF signaling re-
sulted in accelerated healing of exci-
sional wounds. In TNF-receptor p55
knockout mice, enhancement of angio-
genesis, collagen production, and
epithelial wound closure was observed.
Moreover, the expression of TGF-b1
and connective tissue growth factor
were enhanced and higher levels of
vascular endothelial growth factor,
vascular endothelial growth factor re-
ceptor-1, and vascular endothelial
growth factor-2 were also observed.
Overall, the inflammatory activity of
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these wounds was markedly reduced
compared with controls (Mori et al.,
2002). These findings suggest that
inflammatory cytokine signals can bal-
ance TGF-b expression and TGF-b-
mediated effects on healing wounds.
TGF-b expression was analyzed in
full-thickness excisional mouse
wounds at different stages after injury,
and all three isoforms were detected.
Nevertheless, each isoform had a dis-
tinct and characteristic expression pat-
tern and time course in wound healing.
TGF-b1 and -b2 expressions were
rapidly induced in suprabasal wound
keratinocytes and in the stroma, fol-
lowed later by the expression of TGF-
b3 throughout the hyperproliferative
epithelium, and also in the granulation
tissue (Kane et al., 1991; Levine et al.,
1993; Schmid et al., 1993; Frank et al.,
1996). There is also a rapid release of
TGF-b at the site of injury from
degranulating thrombocytes (Assoian
et al., 1983), suggesting that at early
time points, TGF-b is supplied by
thrombocytes, whereas later, keratino-
cytes, macrophages, and fibroblasts
become the predominant source of
TGF-b in wounds. In situ measurement
of TGF-b bioactivity identified a second
peak of active TGF-b (Yang et al.,
1999), which coincides with the ap-
pearance of myofibroblasts.
The phenotype of TGF-b inhibition
in wound healing is complex. Neutra-
lization of TGF-b1 and -b2 with neu-
tralizing antibodies and antisense-
oligonucleotides resulted in reduced
scarring (Shah et al., 1994; Choi
et al., 1996). The analysis of wound
healing in TGF-b1-deficient mice was
very difficult, as these mice show a
severe multifocal inflammatory pheno-
type after 3 weeks of age, leading to
multiple organ failure and death at
o30 days of life (Kulkarni et al.,
1993). When mice were wounded at
day 10, initial wound healing was
normal before high numbers of inflam-
matory cells accumulated, and vascu-
lar density and collagen deposition
were reduced, and epithelial closure
was delayed (Brown et al., 1995). The
conclusion that other TGF-bs were
compensating at early time points is
difficult to draw. Maternal transmission
of TGF-b through the milk – before
complete weaning (Letterio et al.,
1994) – may have ameliorated inflam-
mation at early time points. Later,
inflammation and the subsequent wast-
ing may have prevailed and perturbed
wound healing. Blocking TGF-b signal-
ing in keratinocytes or fibroblasts was
achieved by tissue-specific expression
of a dominant-negative receptor ap-
proach or by using a conditional
knockout strategy, respectively. Wound
closure occurred faster through in-
creased keratinocyte proliferation and
decreased apoptosis in transgenic ani-
mals, which overexpressed a domi-
nant-negative type II TGF-b receptor
mutant in basal keratinocytes (Amendt
et al., 2002). In these animals, signaling
of all TGF-b isoforms is abolished in
basal keratinocytes. When the TGF-b
type II receptor was inactivated in
fibroblasts, the granulation tissue in
excisional wounds had less tensile
strength at day 7. The epidermal
wound closure rate was unaffected,
but, interestingly, the number of supra-
basal keratinocytes was increased, sug-
gesting indirect paracrine effects. In
these mice, the cell type-specific in-
activation was achieved by crossing
mice with two floxed TGF-b type II
receptor alleles with mice expressing
the Cre recombinase under the control
of the fibroblast specific protein-1
promoter, which becomes active in
cells of the fibroblastic lineage after
day 9 of embryonic development
(Bhowmick et al., 2002). These studies
demonstrated that TGF-b activity is
peaking early after wounding and later
in the wound-healing process. Major
TGF-b effects are seen in the granula-
tion tissue with increased extracellular
matrix production; however, it appears
that they occur at the expense of
epidermal wound closure rates. Thus
the balance of proinflammatory cyto-
kines and TGF-b activity appears to
control major aspects of keratinocyte–-
fibroblast interactions in vivo.
Diversity of fibroblasts
Fibroblasts are poorly characterized,
and there is a large variability of
fibroblast phenotypes. Fibroblasts can
be derived from many organs; several
mesenchymal cells such as adipocytes
can de-differentiate into fibroblastic
cells, and dermal fibroblasts can ac-
quire a new differentiation state, for
example, they can differentiate into
myofibroblasts. In keloids, benign tu-
mors characterized by excessive pro-
duction of extracellular matrix, and in
hypertrophic scars, lesional fibroblasts
and keratinocytes differ from those of
nonlesional skin (Ehrlich et al., 1994;
Machesney et al., 1998). mRNA for
activin is increased in keloids, and
activin A and follistatin were found in
basal keratinocytes (Mukhopadhyay
et al., 2006). On the mesenchymal
side, keloid and hypertrohic scar fibro-
blasts show a strong expression of a-
SMA (Ehrlich et al., 1994). The pheno-
type of keloid and control fibroblasts is
also evident in tissue culture. High
baseline expression of activin A, follis-
tatin, a-SMA, collagen I, thrombospon-
din-1, and the ectodermal dysplasia-A
fibronectin variant distinguishes keloid
fibroblasts from normal fibroblasts in
culture (Chipev et al., 2000; Chipev
and Simon, 2002; Mukhopadhyay
et al., 2006). Moreover, hypertrophic
scar fibroblasts showed increased fibrin
gel (Younai et al., 1996) and collagen–-
gel contraction (Phan et al., 2003).
There is also evidence that neutralizing
anti-TGF-b antibodies can partially
revert the keloid fibroblast phenotype
(Younai et al., 1994). To complicate the
situation, several groups have shown
that lesional keratinocytes also differ
from normal keratinocytes. Keloid ker-
atinocytes are more effective in indu-
cing fibroblast proliferation and matrix
production in both keloid and control
fibroblasts (Xia et al., 2004). Moreover,
keratinocytes from keloids are charac-
terized by a higher expression of TGF-
b1, -b2, TGF-b receptor 1, and Smad2
in cocultures, and they express the
hyperproliferative keratins K6, K16,
and K17 with premature expression of
filaggrin (Machesney et al., 1998). At
present, it is unclear how keratinocy-
te–fibroblast interactions in keloids or
hypertrophic scars differ from normal
cells or whether keratinocytes or
fibroblasts are the primary cause for
the keloid or hypertrophic scar pheno-
type. Still, it appears that the phenotype
or differentiation state is stable for a
long time in patients and in tissue
culture.
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Differences in fibroblast differentia-
tion may be more subtle. Comparing
dermal fibroblasts from different layers
of human skin showed differences in
collagen type I and III mRNA expres-
sion (Ali-Bahar et al., 2004). Fibroblasts
derived from deeper layers showed
reduced collagen expression compared
with fibroblasts derived from more
superficial layers. Fibroblast diversity
was further demonstrated by expression
data for fibroblasts derived from differ-
ent body sites (Chang et al., 2002; Rinn
et al., 2006). The analysis showed that
fibroblasts retain positional information
and their topographic differentiation in
tissue culture. The HOX gene expres-
sion pattern in fibroblasts appears to be
a signature from which body site the
cells were derived (Chang et al., 2002).
It is unclear at present how these
differences may influence keratinocy-
te–fibroblast interactions. Recombina-
tion experiments have shown that
keratinocytes maintain their gross ana-
tomical site-specific differentiation pat-
tern (Limat et al., 1996; Okazaki et al.,
2003). On closer examination, there is
evidence that keratinocyte differentia-
tion can be modulated by fibroblast-
derived information cues (Okazaki
et al., 2003). When comparing the
effects of different fibroblast lineages,
the effects on the epithelial phenotype
become more pronounced (Reynolds
and Jahoda, 1992; Aoki et al., 2004).
For rodent dermal papilla cells isolated
from whiskers, the dermal papilla cell
differentiation is sufficiently stable to
survive several passages in tissue cul-
ture, and the cells are still able to
induce hair follicle development with
the necessary reprogramming of inter-
follicular keratinocytes into hair folli-
cles (Reynolds and Jahoda, 1992). In
the other example, Aoki et al. (2004)
compared the effect of bone marrow
stromal cells, subcutaneous preadipo-
cytes, and dermal fibroblasts on the
epidermal architecture of keratinocytes
in three-dimensional cultures. All me-
senchymal cell types supported epider-
mal proliferation and differentiation.
Bone marrow stromal cells and pre-
adipocytes induced in growth of kera-
tinocytes into the fibroblast-populated
dermal equivalents, a process the
authors describe as ‘‘rete ridge-like’’
and ‘‘epidermal ridge-like’’ structure
formation.
The last years have seen significant
advances in the definition of the cells
currently summarized as fibroblasts. It
will be interesting with this knowledge
in mind to review observations on
anatomical site variances on wound
healing rates and skin transplantation
outcomes in patients. Fibroblast differ-
entiation and resulting differences in
keratinocyte–fibroblast interactions
may have a central role in the clinics
of wound-healing and could represent
a novel target for therapeutic interven-
tions (Table 1).
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